English: A female mosquito of the Culicidae family (Culiseta longiareolata). Size: about 10mm length Location: Lisbon region, Portugal Türkçe: Culiseta longiareolata türü di?i bir sivrisinek. (Photo credit: Wikipedia)
Vectored immunoprophylaxis (VIP) injection triggers creation of antibodies that prevent malaria in 70 percent of mice
A study led by Johns Hopkins Bloomberg School of Public Health researchers found that injecting a vaccine-like compound into mice was effective in protecting them from malaria. The findings suggest a potential new path toward the elusive goal of malaria immunization.
Mice injected with a virus genetically altered to help the rodents create an antibody designed to fight the malaria parasite produced high levels of the anti-malaria antibody. The approach, known as Vector immunoprophylaxis, or VIP, has shown promise in HIV studies. It had never before been tested with malaria, for which no licensed vaccine exists.
A report on the research appears online Aug. 11 in the Proceedings of the National Academy of Sciences (PNAS).
Malaria is one of the world’s deadliest infectious diseases, killing as many as 1 million people per year, the majority of them children in Africa. Malaria patients get the disease from infected mosquitoes. Of the four types of malaria that affect humans, the parasite Plasmodium falciparum is the most lethal, responsible for the majority of malaria cases. Antimalarial treatments and mosquito habitat modification have contributed to a decline in malaria mortality. But the number of cases remains high, and stemming them is a top global health priority.
In their study, researchers used a virus containing genes that were encoded to produce an antibody targeted to inhibit P. falciparum infection. Up to 70 percent of the mice injected with the VIP were protected from malaria-infected mosquito bites. In a subset of mice that produced higher levels of serum antibodies, the protection was 100 percent. The mice were tested a year after receiving a single injection of the virus and were shown to still produce high levels of the protective antibody.
The Latest on: Malaria vaccine
via Google News
The Latest on: Malaria vaccine
- Vaccine delivers hope for families hit by malariaon May 15, 2022 at 5:08 pm
Had I known that malaria kills, I would have taken them to hospital earlier,” said the father of 15 with two wives. The first wife lost three of her 11 children while the second wife lost four of her ...
- First malaria vaccine hits 1 million dose milestone — although it has its shortcomingson May 13, 2022 at 2:17 pm
The vaccine couldn't have come at a more critical time, with a surge in cases and deaths from malaria during the pandemic. But its efficacy — and its schedule — are far from ideal.
- First malaria vaccine hits 1 million dose milestoneon May 13, 2022 at 11:24 am
Just such a new tool arrived last fall when the WHO authorized a malaria vaccine — the first ever against a parasitic disease — to be rolled out in Ghana, Kenya and Malawi. And now it's hit a ...
- Rollout of world's first malaria jab gathers paceon May 6, 2022 at 8:35 am
The world's first malaria vaccine will soon be available across sub-Saharan Africa, according to PATH, partners of the vaccine developers, as positive results from the pioneering jab pile up.
- World's first malaria vaccine may be available soon across Sub-Saharan Africaon May 4, 2022 at 5:01 pm
The world's first malaria vaccine will soon be available across Sub-Saharan Africa, according to PATH, partners of the vaccine developers, as positive results from the pioneering jab pile up. The ...
- GeoVax Announces Issuance of Malaria Vaccine Patenton April 28, 2022 at 2:20 am
GeoVax’s Unique Multi-Antigenic Vaccine Approach Designed to Provide Stronger, Broader Protection Against Malaria Atlanta, GA, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire-- GeoVax Labs ...
- The RTS,S malaria vaccine may do more than we thoughton April 27, 2022 at 10:10 am
RTS,S is the first malaria vaccine to be recommended by the WHO for use in African children. The vaccine contains a fragment of the CSP protein, one of the over 5,000 proteins expressed by the P ...
- The RTS,S malaria vaccine may do more than we thoughton April 27, 2022 at 1:34 am
image: Malaria vaccination campaign in Manhiça, Mozambique view more Credit: ISGlobal Antibodies induced by the RTS,S malaria vaccine can bind strongly to other P. falciparum antigens not ...
- Microbiologist charges stakeholders on malaria vaccineson April 26, 2022 at 10:23 pm
A microbiologist from the University of Ilorin, Tajudeen Amuda, has advised the government and other stakeholders to develop local and cost-effective malaria vaccines. In a statement made ...
- GeoVax Announces Issuance of Malaria Vaccine Patenton April 26, 2022 at 9:28 am
Globally, malaria causes 228 million infections and 405,000 deaths annually. Despite decades of vaccine research, vaccine candidates have failed to induce substantial protection (e.g. >50%).
via Bing News
